Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
insulin
Pharma
Novo Nordisk attracts lawmakers' ire for Levemir insulin pull
Novo Nordisk is facing lawmaker pushback over its decision to discontinue its insulin product Levemir, which was due for a steep discount in January.
Fraiser Kansteiner
Apr 18, 2024 10:40am
Lilly, plaintiffs cancel $13.5M insulin pricing settlement
Apr 17, 2024 7:00am
Biocon sells insulin and other brands to Eris for $150M
Mar 14, 2024 11:34am
Eli Lilly inks insulin pricing settlement in Minnesota
Feb 8, 2024 11:40am
FDA hits Biocon's insulin copycat with a CRL
Oct 9, 2023 11:53am
Novo Nordisk taps Aspen to help produce insulin for Africa
Sep 19, 2023 10:16am